Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stump

Showing results (1051-1060 of 1,095) with videos related to

Pageof 110
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 11, 2006
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadTheresa M Williams, Craig A Stump, Diem N Nguyen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor AntagonistIan M Bell, Steven N Gallicchio, Michael R Wood, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexantIzzat T Raheem, Michael J Breslin, Joseph Bruno, et al.
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Cancer Nursing|November 24, 2021
Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology GroupJoan E Haase, Kristin Stegenga, Sheri L Robb, et al.
Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in ratsIan M Bell, Craig A Stump, Steven N Gallicchio, et al.
Pageof 110

Showing results (1051-1060 of 1,095) with videos related to

Sort By:
Pageof 110
Bioorganic & Medicinal Chemistry Letters|March 11, 2006
Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadTheresa M Williams, Craig A Stump, Diem N Nguyen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor AntagonistIan M Bell, Steven N Gallicchio, Michael R Wood, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexantIzzat T Raheem, Michael J Breslin, Joseph Bruno, et al.
The Heart Surgery Forum|May 7, 2010
Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypassR Clive Landis, John M Murkin, David A Stump, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Cancer Nursing|November 24, 2021
Randomized Clinical Trial of a Self-care and Communication Intervention for Parents of Adolescent/Young Adults Undergoing High-Risk Cancer Treatment: A Report From the Children's Oncology GroupJoan E Haase, Kristin Stegenga, Sheri L Robb, et al.
Journal of Medicinal Chemistry|January 26, 2007
Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonistNigel J Liverton, Rodney A Bednar, Bohumil Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
The discovery of highly potent CGRP receptor antagonistsCraig A Stump, Ian M Bell, Rodney A Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in ratsIan M Bell, Craig A Stump, Steven N Gallicchio, et al.
Pageof 110